A detailed history of Tcg Crossover Management, LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 1,989,103 shares of TYRA stock, worth $28 Million. This represents 6.07% of its overall portfolio holdings.

Number of Shares
1,989,103
Previous 1,989,103 -0.0%
Holding current value
$28 Million
Previous $31.8 Million 47.03%
% of portfolio
6.07%
Previous 4.76%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$5.68 - $8.81 $5.93 Million - $9.19 Million
1,043,396 Added 110.33%
1,989,103 $15.1 Million
Q3 2022

Nov 14, 2022

BUY
$6.61 - $12.42 $325,800 - $612,169
49,289 Added 5.5%
945,707 $8.31 Million
Q1 2022

May 16, 2022

BUY
$10.03 - $14.09 $461,059 - $647,689
45,968 Added 5.41%
896,418 $9.59 Million
Q4 2021

Feb 18, 2022

BUY
$12.23 - $31.35 $10.4 Million - $26.7 Million
850,450 New
850,450 $12 Million

Others Institutions Holding TYRA

About Tyra Biosciences, Inc.


  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $591M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Tcg Crossover Management, LLC Portfolio

Follow Tcg Crossover Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Crossover Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Crossover Management, LLC with notifications on news.